For an additional privacy safeguard, you'd be wise to add a privacy screen to your phone. It's designed to darken the view of ...

A Phase 2 clinical trial testing obexelimab in adults with relapsing types of multiple sclerosis is now recruiting ...

In a trial, Gossamer Bio's PAH treatment candidate seralutinib reduced the resistance blood faces moving into the lungs over ...

Qure is planning soon to start enrolling patients in a second dose group as part of a clinical trial testing AMT-162 for SOD1 ...

The first patient has been enrolled in a Phase 1 trial by the NHLBI that's evaluating fostamatinib as a treatment for sickle ...

Merck is ending a Phase 3 trial of Winrevair early so all PAH patients in HYPERION can start active treatment with the drug ...

Masitinib is an oral inhibitor of tyrosine kinases, enzymes important for immune cells thought to drive ALS inflammation and ...

The much-loved ARC Fashion Show supports and celebrates those living with cancer and survivors both through the ARC centres which provide emotional support ...

Regulators in the U.S. and the European Union agreed to review Biogen’s applications for approval of a higher dose Spinraza regimen for SMA.

While many are struggling to keep their doors open, these are the places stepping up to feed our city in times of need. Earlier this month before the fires broke out, we asked more than a dozen ...

This one, though, will be the first at the Australian Open — and the first in the quarterfinals of a tournament; each of the others came in either a semifinal or final. “Well, this is not the ...

The Blue Envelope Program is similar to the Yellow Dot Program, where it aims to assist first responders in providing medical care to individuals who are unable to communicate during emergencies ...